Factor H deficiency and fibrillary glomerulopathy

Nephrology Dialysis Transplantation

Volumn 19, Issue 3, 2004, Pages 727-730

  Bircan, Zelal ^a   Toprak, Demet ^a   Kilicaslan, Isin ^b   Solakoglu, Seyhun ^b   Uysal, Veli ^b   Ponard, Denis ^c   Turker, Gulcan ^a  

^a KOCAELI UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Cyclosporine A; Factor H; Fibrillary glomerulopathy; Nephrotic proteinuria

Indexed keywords

ATENOLOL; CHOLESTEROL; COMPLEMENT FACTOR H; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ENALAPRIL; METHYLPREDNISOLONE; NIFEDIPINE; PREDNISOLONE; PREDNISONE;

ARTICLE; BLOOD PRESSURE REGULATION; CASE REPORT; CHILD; CHOLESTEROL BLOOD LEVEL; COOMBS TEST; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; EYELID EDEMA; FACTOR H DEFICIENCY; GLOMERULONEPHRITIS; GLOMERULOPATHY; HEMATURIA; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPERTENSIVE CRISIS; KIDNEY BIOPSY; LABORATORY TEST; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEINURIA; RELAPSE;

COMPLEMENT FACTOR H; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; INFANT; MALE; PEDIGREE;

EID: 1342263687     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg605     Document Type: Article

References (11)

1. Zipfel PF, Hellwage J, Friese MA, Hegasy G, Jokiranta ST, Meri S. Factor H and disease: a complement regulator affects vital body functions. Mol Immunol 1999; 36: 241-248
2. Ault BH. Factor H and the pathogenesis of renal diseases. Pediatr Nephrol 2000; 14: 1045-1053
3. Warwicker P, Donne RL, Goodship JA et al. Familial relapsing haemolytic uraemic syndrome and complement factor H deficiency. Nephrol Dial Transplant 1999; 14: 1229-1233
4. Ohali M, Shalev H, Schlesinger M et al. Hypocomplementemic autosomal recessive hemolytic uremic syndrome with decreased factor H. Pediatr Nephrol 1998; 12: 619-624
5. Caprioli J, Bettinaglio P, Zipfel PF et al. and the Italian Registry of Familial and Recurrent HUS/TTP. The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J Am Soc Nephrol 2001; 12: 297-307
6. Levy M, Halbwachs-Mecarelli L, Gubler MC et al. Factor H deficiency in two brothers with atypical dense intramembranous deposit disease. Kidney Int 1986; 30: 949-956
7. Lopez-Larrea C, Dieguez M, Enguix A, Dominguez O, Marin B, Gomez F. A familial deficiency of complement factor H. Biochem Soc Trans 1987; 15: 648-649
8. Vogt BA, Wyatt RJ, Burke BA, Simonton SC, Kashtan CE. Inherited factor H deficiency and collagen type III glomerulopathy. Pediatr Nephrol 1995; 9: 11-15
9. Callis L, Vila A, Carrera M, Nieto J. Long term effects of cyclosporine A in Alport's syndrome. Kidney Int 1999; 55: 1051-1056
10. Chen D, Jefferson B, Harvey SC et al. Cyclosporine A slows the progressive renal disease of Alport Syndrome (X-Linked Hereditary Nephritis): results of a canine model. J Am Soc Nephrol 2003; 14: 690-698
11. Pickering MC, Cook HT, Warren J et al. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nature Genet 2002; 31: 424-428